Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling

Blood

Volumn 121, Issue 6, 2013, Pages 930-939

  Fulzele, Keertik ^a   Krause, Daniela S ^a   Panaroni, Cristina ^a   Saini, Vaibhav ^a   Barry, Kevin J ^a   Liu, Xiaolong ^a   Lotinun, Sutada ^b   Baron, Roland ^a,b   Bonewald, Lynda ^c   Feng, Jian Q ^d   Chen, Min ^e   Weinstein, Lee S ^e   Wu, Joy Y ^a   Kronenberg, Henry M ^a   Scadden, David T ^a   Pajevic, Paola Divieti ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CATENIN; GRANULOCYTE COLONY STIMULATING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; NEUTRALIZING ANTIBODY; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; EXPLANT; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC CELL; IN VITRO STUDY; MOUSE; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; OSTEOBLAST; OSTEOCYTE; OSTEOPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; STEM CELL EXPANSION; WNT SIGNALING PATHWAY;

EID: 84873575928     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-437160     Document Type: Article

References (33)

1. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-197. (Pubitemid 30154488)
2. Molofsky AV, Pardal R, Morrison SJ. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol. 2004;16(6):700-707. (Pubitemid 39467731)
3. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008;8(4):290-301. (Pubitemid 351432804)
4. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425(6960):841-846. (Pubitemid 37351468)
5. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425(6960):836-841. (Pubitemid 37351467)
6. Kollet O, Dar A, Shivtiel S, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12(6):657-664. (Pubitemid 43865234)
7. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-1121. (Pubitemid 40884400)
8. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 2008;452(7186): 442-447. (Pubitemid 351450836)
9. Katayama Y, Battista M, Kao WM, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006;124(2):407-421. (Pubitemid 43121987)
10. Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004;20(6):707-718. (Pubitemid 38757441)
11. Wu JY, Purton LE, Rodda SJ, et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways. Proc Natl Acad Sci U S A. 2008;105(44):16976-16981.
12. Avecilla ST, Hattori K, Heissig B, et al. Chemokinemediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10(1):64-71. (Pubitemid 38524700)
13. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004;103(9):3258-3264. (Pubitemid 38525648)
14. Franz-Odendaal TA, Hall BK, Witten PE. Buried alive: how osteoblasts become osteocytes. Dev Dyn. 2006;235(1):176-190. (Pubitemid 46939715)
15. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108(1):17-29. (Pubitemid 34137009)
16. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17(10):1235-1241.
17. Winkler DG, Sutherland MK, Geoghegan JC, et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003;22(23):6267- 6276. (Pubitemid 37522584)
18. Wu M, Deng L, Zhu G, Li YP. G Protein and its signaling pathway in bone development and disease. Front Biosci. 2010;15:957-985.
19. Neves SR, Ram PT, Iyengar R. G protein pathways. Science. 2002;296(5573):1636-1639. (Pubitemid 34579147)
20. Powell WF Jr, Barry KJ, Tulum I, et al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol. 2011;209(1):21-32.
21. Cherian PP, Cheng B, Gu S, Sprague E, Bonewald LF, Jiang JX. Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. J Biol Chem. 2003;278(44):43146-43156. (Pubitemid 37345933)
22. Halleux C, Bassilana F, Kramer I, et al. Assessment of the GPCR landscape in osteocytes reveals novel candidate regulators of bone homeostasis. J Bone Miner Res. 2011;26(Suppl 1): MO0307.
23. Sakamoto A, Chen M, Kobayashi T, Kronenberg HM, Weinstein LS. Chondrocyte-specific knockout of the G protein G(s) alpha leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res. 2005;20(4): 663-671. (Pubitemid 40393075)
24. Lu Y, Xie Y, Zhang S, Dusevich V, Bonewald LF, Feng JQ. DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res. 2007; 86(4):320-325.
25. Kobayashi T, Soegiarto DW, Yang Y, et al. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest. 2005;115(7): 1734-1742. (Pubitemid 40979712)
26. Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem. 2007; 282(35):25649-25658. (Pubitemid 47372844)
27. Poole KE, van Bezooijen RL, Loveridge N, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005;19(13):1842-1844. (Pubitemid 41598769)
28. Li X, Ominsky MS,Warmington KS, et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res. 2009;24(4):578-588.
29. Pang L, Weiss MJ, Poncz M. Megakaryocyte biology and related disorders. J Clin Invest. 2005; 115(12):3332-3338. (Pubitemid 43121816)
30. Metcalf D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science. 1991;254(5031):529-533. (Pubitemid 21917365)
31. Taichman RS, Emerson SG. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med. 1994;179(5):1677-1682. (Pubitemid 24129586)
32. Walkley CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell. 2007;129(6):1097-1110. (Pubitemid 46908696)
33. Terauchi Y, Sakura H, Yasuda K, et al. Pancreatic beta-cell-specific targeted disruption of glucokinase gene: diabetes mellitus due to defective insulin secretion to glucose. J Biol Chem. 1995; 270(51):30253-30256.